We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMTR
11901
CALL
DELISTED
9 Meters Biopharma
NMTR
$197K ﹤0.01%
7,565
+2,185
+41% +$51.5K
CRD.A icon
11902
Crawford & Co Class A
CRD.A
$632M
$196K ﹤0.01%
21,824
-3,450
-14% -$33.8K
INCR
11903
Intercure
INCR
$58.6M
$196K ﹤0.01%
+28,242
New +$203K
IVRA
11904
DELISTED
Invesco Real Assets ESG ETF
IVRA
$196K ﹤0.01%
+13,815
New +$197K
MBIO icon
11905
PUT
Mustang Bio
MBIO
$4.5M
$196K ﹤0.01%
97
+14
+17% +$30.1K
REI icon
11906
PUT
Ring Energy
REI
$357M
$196K ﹤0.01%
66,600
-52,600
-44% -$134K
USIO icon
11907
CALL
Usio Inc
USIO
$78.6M
$196K ﹤0.01%
+33,100
New +$193K
VRRM icon
11908
PUT
Verra Mobility
VRRM
$717M
$196K ﹤0.01%
13,000
-8,500
-40% -$130K
QNTM
11909
CALL
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$196K ﹤0.01%
1,906
+512
+37% +$54.7K
PRSTW
11910
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$196K ﹤0.01%
818,021
+5,504
+0.7% +$1.71K
APGB.U
11911
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$196K ﹤0.01%
19,746
-1,868,538
-99% -$18.6M
CSPR
11912
CALL
DELISTED
Casper Sleep Inc.
CSPR
$196K ﹤0.01%
45,900
-50,000
-52% -$299K
AQMS icon
11913
PUT
Aqua Metals
AQMS
$9.99M
$195K ﹤0.01%
472
-366
-44% -$166K
CALC icon
11914
PUT
CalciMedica
CALC
$20.8M
$195K ﹤0.01%
4,200
-4,186
-50% -$235K
UONE icon
11915
Urban One Class A
UONE
$23.3M
$195K ﹤0.01%
+2,399
New +$179K
ENZ
11916
DELISTED
Enzo Biochem, Inc.
ENZ
$195K ﹤0.01%
54,947
-18,863
-26% -$62.9K
VLD.WS
11917
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$195K ﹤0.01%
+126,435
New +$195K
ELVT
11918
PUT
DELISTED
Elevate Credit, Inc.
ELVT
$195K ﹤0.01%
47,300
-3,500
-7% -$12.6K
ALTG icon
11919
CALL
Alta Equipment Group
ALTG
$237M
$194K ﹤0.01%
14,100
-19,700
-58% -$258K
CLBT icon
11920
Cellebrite
CLBT
$2.79B
$194K ﹤0.01%
+20,920
New +$219K
KRO icon
11921
PUT
KRONOS Worldwide
KRO
$975M
$194K ﹤0.01%
+15,600
New +$206K
ENZ
11922
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$194K ﹤0.01%
54,800
-700
-1% -$2.33K
AGGRW
11923
DELISTED
Agile Growth Corp Warrant
AGGRW
$194K ﹤0.01%
298,232
– –
GROW icon
11924
PUT
US Global Investors
GROW
$39.4M
$193K ﹤0.01%
34,000
-18,200
-35% -$109K
NWBI icon
11925
CALL
Northwest Bancshares
NWBI
$2.31B
$193K ﹤0.01%
+14,500
New +$191K
475 476
477
478 479

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.